Sartorius: Supplementary Information on 2014 Business Figures

BERLIN--()--The Sartorius Group sold its Industrial Technologies Division with economic effect as of January 1, 2015. Therefore, Sartorius Group reporting for the full year of 2014 was already based on continuing operations according to the IFRS International Financial Reporting Standards (see the 2014 Annual Report). In addition to the disclosures made in the annual report, the following supplementary information is provided on business development at the Group and division levels for the regular reporting periods up to and including the full year of 2014 for better comparison with reported future quarterly results:

 
Sartorius Group
 
in millions of €, unless otherwise specified
    3M 2014   6M 2014   9M 2014   FY 2014
Order intake 225.1 440.5 658.1 929.2
Sales revenue 203.1 423.0 645.5 891.2
Cost of sales -105.1 -218.6 -333.3 -461.6
Gross profit on sales 98.0 204.4 312.2 429.6
Selling and distribution costs -48.7 -98.3 -147.2 -200.2
Research and development expenses -13.4 -25.3 -38.2 -50.4
General administrative expenses -14.1 -27.9 -41.9 -58.3
Other operating income | expenses 3.4 5.1 5.2 5.5
Earnings before interest and taxes (EBIT) 25.2 58.0 90.2 126.2
Financial result -4.4 -10.0 -16.3 -29.9
Profit before tax 20.8 48.0 73.9 96.3
Income taxes -6.3 -17.5 -25.1 -32.4
Profit after tax from continuing operations 14.6 30.5 48.7 63.9
Profit after tax from discontinued operation 0.5 1.6 3.4 4.5
Net profit for the period 15.1 32.1 52.1 68.4
Attributable to:        
Equity holders of Sartorius AG 11,0 23.1 37.8 48.5
Non-controlling interest 4.0 9.0 14.3 19.9
         
Reconciliation to Underlying EBITDA        
Extraordinary items 1.2 2.0 4.0 8.3
Amortization | depreciation 12.2 24.8 37.8 52.3
Underlying EBITDA1)   38.7   84.8   131.9   186.8
Underlying EBITA margin in %1)   19.0   20.1   20.4   21.0
 
 
Sartorius Divisions
 
€ in millions, unless otherwise specified
    3M 2014   6M 2014   9M 2014   FY 2014
Bioprocess Solutions        
Order intake 158.1 304.9 460.3 652.7
Sales revenue 137.7 291.1 444.7 615.6
Underlying EBITDA1) 29.6 66.4 103.0 145.6
Underlying EBITDA margin in %1) 21.5 22.8 23.2 23.7
         
Lab Products & Services        
Order intake 67.0 135.7 197.8 276.5
Sales revenue 65.4 131.9 200.8 275.5
Underlying EBITDA1) 9.1 18.4 29.0 41.2
Underlying EBITDA margin in %1) 13.9 14.0 14.4 15.0
 
Reconciliation to the Relevant Net Profit        
in millions of €, unless otherwise specified        
  3M 2014 6M 2014 9M 2014 FY 2014
Earnings before interest and taxes (EBIT) 25.2 58.0 90.2 126.2
Extraordinary items 1.2 2.0 4.0 8.3
Amortization 3.5 7.0 10.6 14.0
Normalized financial result2) -4.3 -10.0 -14.4 -20.2
Normalized income tax3) -7.7 -17.1 -27.1 -38.5
Underlying earnings after taxes 17.9 39.9 63.3 89.8
Non-controlling interest -4.7 -10.6 -16.6 -23.7
Underlying earnings after taxes and non-controlling interest 13.3 29.3 46.6 66.1
per ordinary share (in €) 0.77 1.71 2.72 3.87
per preference share (in €) 0.79 1.73 2.74 3.89
Relevant net profit after non-controlling interest4) 13.8 31.3 50.5 73.7
per ordinary share (in €) 0.80 1.82 2.96 4.31
per preference share (in €)   0.82   1.84   2.98   4.33
 

1) Adjusted for extraordinary items

2) Financial result excluding fair value adjustments of hedging instruments and non-periodic expenses and income

3) Underlying income tax, based on the underlying profit before taxes and non-cash amortization

4) Including discontinued operation

 

A Profile of Sartorius

The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider covering the two segments of Bioprocess Solutions and Lab Products & Services. In 2014, the technology group earned sales revenue of 891.2 million euros. Founded in 1870, the Goettingen-based company currently employs more than 5,500 persons. The major areas of activity of its Bioprocess Solutions segment cover filtration, fluid management, fermentation, cell cultivation and purification, and focus on production processes in the biopharmaceutical industry. The Lab Products & Services segment primarily manufactures laboratory instruments and lab consumables. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.

Contacts

Sartorius AG
Petra Kirchhoff, +49 (0)551-308-1686
Vice President of Group Communications and IR
petra.kirchhoff@sartorius.com

Contacts

Sartorius AG
Petra Kirchhoff, +49 (0)551-308-1686
Vice President of Group Communications and IR
petra.kirchhoff@sartorius.com